Cargando…
Treatment of Liver Metastases from Midgut Neuroendocrine Tumours: A Systematic Review and Meta-Analysis
Strong evidence comparing different treatment options for liver metastases (LM) arising from gastroenteropancreatic neuroendocrine tumours (GEP-NET) is lacking. The aim of this study was to determine which intervention for LMs from GEP-NETs shows the longest overall survival (OS). A systematic searc...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462926/ https://www.ncbi.nlm.nih.gov/pubmed/30909512 http://dx.doi.org/10.3390/jcm8030403 |
_version_ | 1783410661293817856 |
---|---|
author | Kaçmaz, Enes Heidsma, Charlotte M. Besselink, Marc G. H. Dreijerink, Koen M. A. Klümpen, Heinz-Josef Nieveen van Dijkum, Elisabeth J. M. Engelsman, Anton F. |
author_facet | Kaçmaz, Enes Heidsma, Charlotte M. Besselink, Marc G. H. Dreijerink, Koen M. A. Klümpen, Heinz-Josef Nieveen van Dijkum, Elisabeth J. M. Engelsman, Anton F. |
author_sort | Kaçmaz, Enes |
collection | PubMed |
description | Strong evidence comparing different treatment options for liver metastases (LM) arising from gastroenteropancreatic neuroendocrine tumours (GEP-NET) is lacking. The aim of this study was to determine which intervention for LMs from GEP-NETs shows the longest overall survival (OS). A systematic search was performed in MEDLINE, Embase and the Cochrane Library in February 2018. Studies reporting on patients with LMs of any grade of sporadic GEP-NET comparing two intervention groups were included for analysis. Meta-analyses were performed where possible. Eleven studies, with a total of 1108, patients were included; 662 patients had LM from pancreatic NETs (pNET), 164 patients from small-bowel NETs (SB-NET) and 282 patients of unknown origin. Improved 5-year OS was observed for surgery vs. chemotherapy (OR 0.05 95% CI [0.01, 0.21] p < 0.0001), for surgery vs. embolization (OR 0.18 95% CI [0.05, 0.61] p = 0.006) and for LM resection vs. no LM resection (OR 0.15 95% CI [0.05, 0.42] p = 0.0003). This is the largest meta-analysis performed comparing different interventions for LMs from GEP-NETs. Despite the high risk of bias and heterogeneity of data, surgical resection for all tumour grades results in the longest overall survival. Chemotherapy and embolization should be considered as an alternative in case surgery is not feasible. |
format | Online Article Text |
id | pubmed-6462926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64629262019-04-19 Treatment of Liver Metastases from Midgut Neuroendocrine Tumours: A Systematic Review and Meta-Analysis Kaçmaz, Enes Heidsma, Charlotte M. Besselink, Marc G. H. Dreijerink, Koen M. A. Klümpen, Heinz-Josef Nieveen van Dijkum, Elisabeth J. M. Engelsman, Anton F. J Clin Med Article Strong evidence comparing different treatment options for liver metastases (LM) arising from gastroenteropancreatic neuroendocrine tumours (GEP-NET) is lacking. The aim of this study was to determine which intervention for LMs from GEP-NETs shows the longest overall survival (OS). A systematic search was performed in MEDLINE, Embase and the Cochrane Library in February 2018. Studies reporting on patients with LMs of any grade of sporadic GEP-NET comparing two intervention groups were included for analysis. Meta-analyses were performed where possible. Eleven studies, with a total of 1108, patients were included; 662 patients had LM from pancreatic NETs (pNET), 164 patients from small-bowel NETs (SB-NET) and 282 patients of unknown origin. Improved 5-year OS was observed for surgery vs. chemotherapy (OR 0.05 95% CI [0.01, 0.21] p < 0.0001), for surgery vs. embolization (OR 0.18 95% CI [0.05, 0.61] p = 0.006) and for LM resection vs. no LM resection (OR 0.15 95% CI [0.05, 0.42] p = 0.0003). This is the largest meta-analysis performed comparing different interventions for LMs from GEP-NETs. Despite the high risk of bias and heterogeneity of data, surgical resection for all tumour grades results in the longest overall survival. Chemotherapy and embolization should be considered as an alternative in case surgery is not feasible. MDPI 2019-03-22 /pmc/articles/PMC6462926/ /pubmed/30909512 http://dx.doi.org/10.3390/jcm8030403 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kaçmaz, Enes Heidsma, Charlotte M. Besselink, Marc G. H. Dreijerink, Koen M. A. Klümpen, Heinz-Josef Nieveen van Dijkum, Elisabeth J. M. Engelsman, Anton F. Treatment of Liver Metastases from Midgut Neuroendocrine Tumours: A Systematic Review and Meta-Analysis |
title | Treatment of Liver Metastases from Midgut Neuroendocrine Tumours: A Systematic Review and Meta-Analysis |
title_full | Treatment of Liver Metastases from Midgut Neuroendocrine Tumours: A Systematic Review and Meta-Analysis |
title_fullStr | Treatment of Liver Metastases from Midgut Neuroendocrine Tumours: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Treatment of Liver Metastases from Midgut Neuroendocrine Tumours: A Systematic Review and Meta-Analysis |
title_short | Treatment of Liver Metastases from Midgut Neuroendocrine Tumours: A Systematic Review and Meta-Analysis |
title_sort | treatment of liver metastases from midgut neuroendocrine tumours: a systematic review and meta-analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462926/ https://www.ncbi.nlm.nih.gov/pubmed/30909512 http://dx.doi.org/10.3390/jcm8030403 |
work_keys_str_mv | AT kacmazenes treatmentoflivermetastasesfrommidgutneuroendocrinetumoursasystematicreviewandmetaanalysis AT heidsmacharlottem treatmentoflivermetastasesfrommidgutneuroendocrinetumoursasystematicreviewandmetaanalysis AT besselinkmarcgh treatmentoflivermetastasesfrommidgutneuroendocrinetumoursasystematicreviewandmetaanalysis AT dreijerinkkoenma treatmentoflivermetastasesfrommidgutneuroendocrinetumoursasystematicreviewandmetaanalysis AT klumpenheinzjosef treatmentoflivermetastasesfrommidgutneuroendocrinetumoursasystematicreviewandmetaanalysis AT nieveenvandijkumelisabethjm treatmentoflivermetastasesfrommidgutneuroendocrinetumoursasystematicreviewandmetaanalysis AT engelsmanantonf treatmentoflivermetastasesfrommidgutneuroendocrinetumoursasystematicreviewandmetaanalysis |